Lilly COVID-19 Antibody Has Role As Stopgap When Too Late To Vaccinate
Bamlanivimab Prevented Infections In Nursing Home Residents
Executive Summary
The company will seek emergency use authorization to prevent outbreaks in nursing homes. Regeneron is also positioning its antibody cocktail to prevent infections.
You may also be interested in...
Regeneron COVID-19 Antibody Poised To Add Prevention Claim, Sub-Q Formula
The company is requesting FDA expand the antibody cocktail to include a COVID prevention claim with a lower 1,200mg dose and a subcutaneously administered formula.
IPO Year In Review: Record-Year Bodes Well For 2021, And For More SPACs
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Regeneron Antibodies Prevent Symptomatic COVID-19 In Interim Phase III Data
The company said data show a lower overall infection rate and no symptomatic infections among participants receiving the drug, compared with placebo.